ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Sees Significant Decline in Short Interest

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totaling 13,369 shares, a decrease of 78.3% from the August 31st total of 61,681 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average trading volume of 33,735 shares, the short-interest ratio is currently 0.4 days.

Institutional Trading of ALPS Medical Breakthroughs ETF

Institutional investors have recently made changes to their positions in the stock. Harbor Investment Advisory LLC purchased a new position in ALPS Medical Breakthroughs ETF during the second quarter valued at approximately $29,000. Virtu Financial LLC increased its stake in ALPS Medical Breakthroughs ETF by 7.3% in the 4th quarter. Virtu Financial LLC now owns 17,967 shares of the company’s stock valued at $920,000 after buying an additional 1,229 shares during the period. Kestra Advisory Services LLC lifted its position in ALPS Medical Breakthroughs ETF by 27.6% in the 1st quarter. Kestra Advisory Services LLC now owns 8,186 shares of the company’s stock worth $428,000 after buying an additional 1,772 shares in the last quarter. Sterling Investment Advisors Ltd. lifted its position in ALPS Medical Breakthroughs ETF by 8.1% in the 2nd quarter. Sterling Investment Advisors Ltd. now owns 23,800 shares of the company’s stock worth $1,539,000 after buying an additional 1,775 shares in the last quarter. Finally, Silver Oak Securities Incorporated lifted its position in ALPS Medical Breakthroughs ETF by 24.4% in the 1st quarter. Silver Oak Securities Incorporated now owns 16,589 shares of the company’s stock worth $868,000 after buying an additional 3,254 shares in the last quarter.

ALPS Medical Breakthroughs ETF Trading Down 1.7%

NYSEARCA SBIO traded down $0.99 during trading on Friday, reaching $57.56. 36,976 shares of the company’s stock were exchanged, compared to its average volume of 38,268. ALPS Medical Breakthroughs ETF has a fifty-two week low of $37.04 and a fifty-two week high of $70.85. The company’s fifty day simple moving average is $65.54 and its 200-day simple moving average is $58.96.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.